This contract involves the supply, installation, and commissioning of a formulation and filling equipment designed to mix cellular products uniformly for the final CART product formulation. This equipment will be used by the Immunology Service (Immunotherapy Section) at the Hospital Clínico de Barce
Tender closed on 13 Mar 2026. Awaiting award.
The Hospital Clínic de Barcelona (HCB) is seeking suppliers for the provision of Prosigna reagents. These reagents are essential for analyzing the PAM50 gene expression signature, which has prognostic value in the management of breast cancer. This opportunity is aimed at suppliers who can deliver hi
The Consorci Hospital Clínic de Barcelona (HCB) is seeking suppliers for the provision of various exclusive pharmaceuticals from Merck Europe B.V. This contract, valued at approximately €3,988,817.08, aims to enhance the healthcare services provided by the hospital. Interested suppliers should refer
The Consorci Hospital Clínic de Barcelona (HCB) is seeking suppliers for the provision of implantable defibrillators and electrodes. This contract is aimed at enhancing cardiac care at the Instituto Clínico Cardiovascular within the Hospital Clínic de Barcelona. The total value of the contract is ap
This contract involves the supply of drainage, aspiration, and irrigation systems for the Hospital Clínic de Barcelona. The total value of the contract is approximately €542,967.38. Suppliers are invited to provide these medical systems to support healthcare services at the hospital. For more detail
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
